van Dam GM - Search Results

1

Implementation and benchmarking of a novel analytical framework to clinically evaluate tumor-specific fluorescent tracers.

Koller M, Qiu SQ, Linssen MD, Jansen L, Kelder W, de Vries J, Kruithof I, Zhang GJ, Robinson DJ, Nagengast WB, Jorritsma-Smit A, van der Vegt B, van Dam GM. Koller M, et al. Among authors: van dam gm, van der vegt b. Nat Commun. 2018 Sep 18;9(1):3739. doi: 10.1038/s41467-018-05727-y. Nat Commun. 2018. PMID: 30228269 Free PMC article. Clinical Trial.

2

Obtaining adequate surgical margins in breast-conserving therapy for patients with early-stage breast cancer: current modalities and future directions.

Pleijhuis RG, Graafland M, de Vries J, Bart J, de Jong JS, van Dam GM. Pleijhuis RG, et al. Among authors: van dam gm. Ann Surg Oncol. 2009 Oct;16(10):2717-30. doi: 10.1245/s10434-009-0609-z. Epub 2009 Jul 17. Ann Surg Oncol. 2009. PMID: 19609829 Free PMC article. Review.

3

Sentinel node mapping with indocyanine green (ICG) and infrared ray detection in early gastric cancer: an accurate method that enables a limited lymphadenectomy.

Kelder W, Nimura H, Takahashi N, Mitsumori N, van Dam GM, Yanaga K. Kelder W, et al. Among authors: van dam gm. Eur J Surg Oncol. 2010 Jun;36(6):552-8. doi: 10.1016/j.ejso.2010.04.007. Epub 2010 May 7. Eur J Surg Oncol. 2010. PMID: 20452171

4

Enhancing surgical vision by using real-time imaging of αvβ3-integrin targeted near-infrared fluorescent agent.

Themelis G, Harlaar NJ, Kelder W, Bart J, Sarantopoulos A, van Dam GM, Ntziachristos V. Themelis G, et al. Among authors: van dam gm. Ann Surg Oncol. 2011 Nov;18(12):3506-13. doi: 10.1245/s10434-011-1664-9. Epub 2011 Apr 21. Ann Surg Oncol. 2011. PMID: 21509632

5

Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results.

van Dam GM, Themelis G, Crane LM, Harlaar NJ, Pleijhuis RG, Kelder W, Sarantopoulos A, de Jong JS, Arts HJ, van der Zee AG, Bart J, Low PS, Ntziachristos V. van Dam GM, et al. Among authors: van der zee ag. Nat Med. 2011 Sep 18;17(10):1315-9. doi: 10.1038/nm.2472. Nat Med. 2011. PMID: 21926976

6

Intraoperative near-infrared fluorescence tumor imaging with vascular endothelial growth factor and human epidermal growth factor receptor 2 targeting antibodies.

Terwisscha van Scheltinga AG, van Dam GM, Nagengast WB, Ntziachristos V, Hollema H, Herek JL, Schröder CP, Kosterink JG, Lub-de Hoog MN, de Vries EG. Terwisscha van Scheltinga AG, et al. Among authors: van dam gm. J Nucl Med. 2011 Nov;52(11):1778-85. doi: 10.2967/jnumed.111.092833. Epub 2011 Oct 11. J Nucl Med. 2011. PMID: 21990576 Free article.

7

Real-time near infrared fluorescence (NIRF) intra-operative imaging in ovarian cancer using an α(v)β(3-)integrin targeted agent.

Harlaar NJ, Kelder W, Sarantopoulos A, Bart J, Themelis G, van Dam GM, Ntziachristos V. Harlaar NJ, et al. Among authors: van dam gm. Gynecol Oncol. 2013 Mar;128(3):590-5. doi: 10.1016/j.ygyno.2012.12.011. Epub 2012 Dec 19. Gynecol Oncol. 2013. PMID: 23262209

8

A validated web-based nomogram for predicting positive surgical margins following breast-conserving surgery as a preoperative tool for clinical decision-making.

Pleijhuis RG, Kwast AB, Jansen L, de Vries J, Lanting R, Bart J, Wiggers T, van Dam GM, Siesling S. Pleijhuis RG, et al. Among authors: van dam gm. Breast. 2013 Oct;22(5):773-9. doi: 10.1016/j.breast.2013.01.010. Epub 2013 Feb 23. Breast. 2013. PMID: 23462681

9

Feasibility of vascular endothelial growth factor imaging in human atherosclerotic plaque using (89)Zr-bevacizumab positron emission tomography.

Golestani R, Zeebregts CJ, Terwisscha van Scheltinga AG, Lub-de Hooge MN, van Dam GM, Glaudemans AW, Dierckx RA, Tio RA, Suurmeijer AJ, Boersma HH, Nagengast WB, Slart RH. Golestani R, et al. Among authors: van dam gm. Mol Imaging. 2013 Jun;12(4):235-43. Mol Imaging. 2013. PMID: 23651501

10

89Zr-bevacizumab PET imaging in primary breast cancer.

Gaykema SB, Brouwers AH, Lub-de Hooge MN, Pleijhuis RG, Timmer-Bosscha H, Pot L, van Dam GM, van der Meulen SB, de Jong JR, Bart J, de Vries J, Jansen L, de Vries EG, Schröder CP. Gaykema SB, et al. Among authors: van der meulen sb, van dam gm. J Nucl Med. 2013 Jul;54(7):1014-8. doi: 10.2967/jnumed.112.117218. Epub 2013 May 7. J Nucl Med. 2013. PMID: 23651946 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

205 results

Search Page

Filters